Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.
Life Sciences 2023 Year End Review / 2024 Outlook - Gibson Dunn
Healthcare Industry News Weekly Wrap-Up: November 11, 2022
2023 Brand Entertainment Awards winners revealed
Evaluate Search
SBFM Stock Alert: Why Sunshine Biopharma Is Up 80% Today
Astrazeneca, GSK And PureTech Set Sights on $1.1trn Biopharma
Few biopharma risers stand out at the half year
Biopharmaceutical Market Size, Share and Analysis
PRWeek US Awards 2022 shortlist revealed
Evaluate Search
VC funding trends in biotechnology
Markets News, Oct. 3, 2023: Dow, S&P 500 Fall to 4-Month Lows as